WHO meeting could change strain selection for flu vaccines

A World Health Organization meeting on flu vaccines kicked off today in Hong Kong, the first time such a meeting has taken place outside of Geneva, where the WHO is headquartered. Health officials and experts will discuss ways to improve global surveillance of the flu and expedite the selection process for which flu strains to include in the vaccine each year. South China Morning Post story

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.